3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial



le Roux, Carel W, Astrup, Arne, Fujioka, Ken, Greenway, Frank, Lau, David CW, Van Gaal, Luc, Ortiz, Rafael Violante, Wilding, John PH ORCID: 0000-0003-2839-8404, Skjoth, Trine V, Manning, Linda Shapiro
et al (show 2 more authors) (2017) 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. LANCET, 389 (10077). 1399 - 1409.

[img] Text
LeRoux_2016_Lancet_1839 primary_10Nov_clean.doc - Accepted Version

Download (301kB)
Item Type: Article
Depositing User: Symplectic Admin
Date Deposited: 03 Apr 2017 10:04
Last Modified: 14 Nov 2019 22:13
DOI: 10.1016/S0140-6736(17)30069-7
Related URLs:
URI: http://livrepository.liverpool.ac.uk/id/eprint/3006773
Repository Staff Access